- Patients
- Clinical Research
- Find a clinical trial
- VIKTORIA-1
Breast Cancer
VIKTORIA-1
Phase 3, open-label, randomized, clinical trial evaluating the efficacy and safety of Gedatolisib plus Fulvestrant with or without Palbociclib for the treatment of patients with locally advanced or metastatic HR+/HER2- breast cancer following progression on or after CDK4/6 and aromatase inhibitor therapy.
Trial overview
Medical Oncology
Breast
III
Registration number: NCT05501886
St Andrew's Precinct (Oncology)
Level 1, 337 South Terrace, Adelaide, SA, 5000, Australia
(08) 8228 6700 infooncologysa@genesiscare.comMedical Oncologist
A/Prof Nick Murray
BM MS MA DPhil FRCP(Lon) FRACP
St Andrew's Precinct (Oncology)
Disclaimer:
This website is provided for information purposes only. Nothing on this website is intended to be used as medical advice, or to diagnose, treat, cure or prevent any disease. It should not be used as a substitute for your own health professional's advice. Any medical procedure or treatment carries risks. Before proceeding with treatment, you should discuss the risks and benefits of the treatment with an appropriately qualified health practitioner. Individual treatment outcomes and experiences will vary.